ORTHOPEDIATRICS CORP KIDS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2017-10-12
ORTHOPEDIATRICS CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M |
| R&D expense | $9.1M | $11.0M | $10.9M | $8.5M | $5.5M |
| Operating income | -$39.2M | -$35.0M | -$26.8M | -$25.4M | -$18.0M |
| Income tax | $460,000 | -$4.1M | -$338,000 | -$4.9M | -$1.1M |
| Net income | -$39.6M | -$37.8M | -$21.0M | $1.3M | -$16.3M |
| EPS (diluted) | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 |
| Operating cash flow | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M |
| Free cash flow | -$16.0M | -$41.3M | -$43.9M | -$31.8M | -$21.2M |
| Cash & equivalents | $19.6M | $43.8M | $31.1M | $9.0M | $7.6M |
| Inventory | $133.8M | $117.0M | $105.9M | $78.2M | $57.6M |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M |
| Shareholders' equity | $346.6M | $354.6M | $377.0M | $378.6M | $225.4M |
Source: SEC EDGAR filings · CIK 0001425450 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.